Stock Rich List
#1987 on the rich list of 14,644 insiders

John Maraganore

Chief Executive Officer at Alnylam Pharmaceuticals; Director at City Therapeutics; Director at Hemab Therapeutics Holdings. Based in Boston, Massachusetts.

$70.5M
in disclosed stock, +$3.1M (+4.65%) today
Live prices, last trade 2:49 PM ET
Rank
1987th of 14,644
Companies held
6
Largest holding
ALNY, 48.9% of total
Latest SEC filing
Oct 22, 2026
Listed but not counted
$223K

What the $70.5M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Alnylam Pharmaceuticals ALNY
Common Stock
Directly227,663$149.37$34.0M48.2%Form 4, Dec 22, 2021
City Therapeutics CTY
Common Stock
Directly1,470,692$18.39$27.0M38.4%Form 4, Oct 19, 2026
City Therapeutics CTY
Common Stock
Through John M. Maraganore 2021 Irrevocable Trust318,507$18.39$5.9M8.3%Form 4, Oct 15, 2026
Hemab Therapeutics Holdings COAG
Common Stock
Directly35,948$39.35$1.4M2.0%Form 4, May 4, 2026
Agios Pharmaceuticals AGIO
Common stock
Directly28,528$29.12$831K1.2%Form 5, Sep 20, 2022
ProKidney PROK
Class B Ordinary Shares
Directly614,013$1.08$660K0.9%Form 4, Jul 11, 2022
Alnylam Pharmaceuticals ALNY
Common Stock
Through Managed Account3,133$149.37$468K0.7%Form 4, Dec 21, 2021
Rapport Therapeutics RAPP
Common Stock
Through John M. Maraganore Revocable Trust9,411$23.56$222K0.3%Form 4, Oct 22, 2026

Share counts are the amounts John Maraganore reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on John Maraganore's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Takeda Pharmaceutical Company TAK
Ordinary Shares
Directly
Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio
10,400$21.45$223K—Form 4, Jul 1, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 22, 2026BoughtRAPP8,239$26.38$217KView
Oct 22, 2026BoughtRAPP1,172$26.92$32KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1984Michael E. Maroone
Director, Carvana. Tempe, AZ
$70.6M−$2.7M (−3.70%)
1985Steven Henry Gunby
CEO, Chairman and President, FTI Consulting. Washington, DC
$70.5M−$888K (−1.24%)
1986Satish Chitoori
Chief Operations Officer, Bloom Energy. San Jose, CA
$70.5M+$335K (+0.48%)
1987John Maraganore
Chief Executive Officer, Alnylam Pharmaceuticals. Boston, MA
$70.5M+$3.1M (+4.65%)
1988Bancorp Mhc Winchester
10% owner, Winchester Bancorp. Winchester, MA
$70.4M−$307K (−0.43%)
1989Krishna Kantheti
10% owner, Ouster. Miami, FL
$70.2M−$1.3M (−1.88%)
1990Andreas Wicki
Director, Harmony Biosciences Holdings
$70.2M−$881K (−1.24%)

Other Alnylam Pharmaceuticals insiders

All ALNY insiders

Questions

How much stock does John Maraganore own?

John Maraganore holds $70,495,498 in listed stock based on SEC filings and current prices, mostly Alnylam Pharmaceuticals (ALNY). That ranks 1987th on the Stock Rich List.

Is this John Maraganore's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did John Maraganore last buy or sell stock?

The most recent open-market trade on file is a purchase of 8,239 RAPP shares on Oct 22, 2026 at $26.38.